676-Dupilumab increases levels of bone growth biomarker irrespective of prior use of systemic corticosteroids in children with moderate-to-severe atopic dermatitis

被引:0
|
作者
Irvine, Alan D. [1 ]
Paller, Amy S. [2 ,3 ]
Hamon, Sara [4 ]
Horowitz, Julie [4 ]
Farrell, Annamaria [4 ]
Hatsell, Sarah [4 ]
Ehmann, Peter [4 ]
Rodriguez Marco, Ainara [5 ]
Bansal, Ashish [4 ]
Chen, Zhen [4 ]
Levy, Stephane [4 ]
Cyr, Sonya L. [4 ]
机构
[1] Trinity Coll Dublin, Dublin, Ireland
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[4] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[5] Sanofi, Madrid, Spain
关键词
atopic dermatitis; pediatric; bone alkaline phosphatase; dupilumab;
D O I
10.1093/bjd/ljae266.050
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
676
引用
收藏
页数:2
相关论文
共 50 条
  • [21] DUPILUMAB REDUCES ITCH IN CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AGED 6 MONTHS TO 5 YEARS
    Paller, A. S.
    Siegfried, E. C.
    Yosipovitch, G.
    Kwatra, S. G.
    Praestgaard, A.
    Prescilla, R.
    Wang, J.
    VALUE IN HEALTH, 2023, 26 (06) : S57 - S58
  • [22] Dupilumab Reduces Itch in Children with Moderate-to-Severe Atopic Dermatitis Aged 6 Months to 5 Years
    Paller, Amy S.
    Siegfried, Elaine C.
    Yosipovitch, Gil
    Kwatra, Shawn G.
    Praestgaard, Amy
    Wang, Zhixiao
    Prescilla, Randy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB151 - AB151
  • [23] Dupilumab treatment reduces total IgE levels in patients 6 months and older with moderate-to-severe atopic dermatitis
    Siegfried, Elaine C.
    Cork, Michael J.
    Boguniewicz, Mark
    Deleuran, Mette
    Simpson, Eric L.
    Chen, Zhen
    Clearfield, Drew
    Shah, Parul
    Rodriguez Marco, Ainara
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [24] Dupilumab Treatment Reduces Total IgE Levels in Patients 6 Months and Older with Moderate-to-Severe Atopic Dermatitis
    Siegfried, Elaine
    Cork, Michael
    Boguniewicz, Mark
    Deleuran, Mette
    Simpson, Eric
    Chen, Zhen
    Clearfield, Drew
    Shah, Parul
    Rodriguez-Marco, Ainara
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB149 - AB149
  • [25] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Cork, Michael J.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sun, Yiping
    O'Malley, John T.
    Bansal, Ashish
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 12 - 12
  • [26] EFFICACY AND SAFETY OF DUPILUMAB TREATMENT UP TO 1 YEAR IN INFANTS AND PRESCHOOL CHILDREN WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Cork, Michael J.
    Paller, Amy S.
    Siegfried, Elaine C.
    Xiao, Jing
    Prescilla, Randy
    Dubost-Brama, Ariane
    Bansal, Ashish
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 53 - 53
  • [27] Efficacy and safety of dupilumab in children aged ≥ 6 months to < 6 years with moderate-to-severe atopic dermatitis
    Paller, A. S.
    Simpson, E. L.
    Siegfried, E. C.
    Cork, M. J.
    Wollenberg, A.
    Arkwright, P. D.
    Soong, W.
    Gonzalez, M. E.
    Schneider, L. C.
    Sidbury, R.
    Lockshin, B.
    Wang, Z.
    Mannent, L. P.
    Amin, N.
    Sun, Y.
    Laws, E.
    Akinlade, B.
    Kosloski, M. P.
    Dubost-Brama, A.
    O'Malley, J. T.
    Bansal, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E173 - E173
  • [28] Efficacy and safety of dupilumab in children aged ≥6 months to <6 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Siegfried, Elaine C.
    Simpson, Eric L.
    Wollenberg, Andreas
    Gonzalez, Mercedes E.
    Sidbury, Robert
    Lockshin, Benjamin
    Xiao, Jing
    O'Malley, John T.
    Bansal, Ashish
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 561 - 561
  • [29] Dupilumab reduces systemic corticosteroid exposure in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbations
    Hamelmann, Eckard
    Deschildre, Antoine
    Ducharme, Francine M.
    Sher, Lawrence D.
    De Mir, Ines
    Xia, Changming
    Gall, Rebecca
    Ledanois, Olivier
    Jacob-Nara, Juby A.
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [30] Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A.
    Wollenberg, A.
    Simpson, E.
    Beck, L.
    Hong, C-H
    Marcoux, D.
    Chen, Z.
    Levit, N.
    Bansal, A.
    Rossi, A.
    Chao, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 57 - 58